Merck KGaA agreed to buy Millipore Corp, a supplier of drug-development equipment for biotechnology companies, for about US$6 billion in cash, beating a rival offer from Thermo Fisher Scientific Inc.
Merck will pay US$107 a share, the Darmstadt, Germany-based company said in a statement. The offer is 13 percent more than Millipore’s closing price on Friday and 50 percent higher than that on Feb. 19, the last day of trading before Bloomberg reported Millipore got a takeover bid.
After the acquisition, Merck, the world’s largest producer of liquid crystals used to make flat-panel TV, will get about 35 percent of its revenue from chemicals, up from about 25 percent currently, Merck spokeswoman Phyllis Carter said. Merck will also gain Millipore’s expertise in testing and making biotechnology drugs, said Ross Muken, a Deutsche Bank AG analyst.
“The angle for Merck is access to high-growth biologics,” Muken said in a telephone interview. Millipore allows Merck, seller of the cancer drug Erbitux outside the US, an opportunity to expand into biotechnology “without the pipeline risk,” said Muken, who has a “hold” rating on Millipore and doesn’t own shares in the company.
Millipore, based in Billerica, Massachusetts, put itself up for sale after getting an unsolicited takeover bid worth less than US$95 a share from Thermo Fisher, said people with knowledge of the matter. General Electric Co is among other companies that weighed a bid during the auction, which was run by Goldman Sachs Group Inc, these people said.
Merck fell 0.49 euros, or 0.9 percent, to 57.31 euros at 9:05am in Frankfurt trading. Before yesterday, the stock had fallen 2.8 percent in the past year, compared with a 30 percent increase in the Bloomberg Europe Pharmaceutical Index.
Karen Kirkwood, a spokeswoman for Thermo Fisher, didn’t immediately respond to calls and an e-mail sent outside regular business hours. Kirkwood declined to comment Sunday when asked about the possibility of Thermo Fisher being outbid by another company.
Millipore had long-term debt of US$890 million as of Dec. 31. Merck valued the acquisition at about US$7.2 billion, including debt. Merck will use available cash and a bridge loan provided by Bank of America Corp, BNP Paribas and Commerzbank AG to finance the purchase.
“This acquisition is a further, important step in the transformation of Merck,” chief executive officer Karl-Ludwig Kley said in a conference call yesterday. The price Merck is paying is “fair” and the acquisition will contribute to the German company’s core earnings per share “from day one,” he said.
Millipore is well-positioned in the market for researching and producing biotechnology drugs, the companies said in their statement. Merck will also gain Millipore’s comprehensive range of products, technologies and services used by drug companies and universities to improve lab productivity and manufacturing, the companies said.
“Millipore can offer a full work flow for a biotech customer,” Deutsche Bank’s Muken said. “They probably have the widest array of products for that biomanufacturing market of any other players out there.”
Last year, Millipore generated sales of US$1.7 billion, with about 6,000 employees in more than 30 countries, according to the statement.
Merck said last year it was seeking acquisitions to bolster its chemicals business as margins from liquid crystals slipped to less than 50 percent. Merck is being advised on Millipore by Guggenheim Securities and Perella Weinberg Partners. Goldman Sachs is Millipore’s financial adviser, the statement said.
Millipore will contribute immediately to core earnings per share and generate cost synergies of about US$100 million annually three years after the closing of the deal, Merck’s Carter said.
The announcement “is a validation of the tremendous value of the Millipore brand and a testament to the value this transformation has created for all of our stakeholders,” Martin Madaus, president and CEO of Millipore, said in the statement. “We are excited to join a high-quality company like Merck as we will gain greater scale and scope in the life science industry.”
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source